DIURETICS AS ANTIHYPERTENSIVE DRUGS: IS IT NECESSARY TO SEARCH FOR THE BEST IN CLASS?


Cite item

Full Text

Abstract

In recent years, the possible advantages of some thiazide and tiazide-like diuretics in terms of effectiveness and fewer adverse events are actively discussing. The article presents consentient and controversial positions regarding the choice of thiazide and tiazide-like diuretics for the treatment of hypertension.

About the authors

V Fomin

Viktor Viktorovich Fomin

References

  1. Российское медицинское общество по артериальной гипертонии - Всероссийское научное общество кардиологов. Диагностика и лечение артериальной гипертензии. Российские рекомендации (третий пересмотр.). М., 2008.
  2. Dahlof B, Sever PS, Poulter NR, et al.; ASCOT Investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005;366:895-906.
  3. Reungjui S, Pratipanawatr T, Johnson RJ, et al. Do thiazides worsen metabolic syndrome and renal disease? The pivotal roles for hyperuricemia and hypokalemia. Curr Opin Nephrol Hypertens 2008;17(5):470-76.
  4. Lindholm LH, Carlberg B, Samuelsson O. Should beta-blockers remain first-choice in the treatment of primary hypertension? A meta-analysis. Lancet 2005;366:1545-53.
  5. Chalmers J, MacMahon S, Manchia G, et al. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens 1999;21(5-6):1009-60.
  6. Shafi T, Appel LJ, Miller ER, et al. Changes in serum potassium mediates thiazide-induced diabetes. Hypertension 2008;52:1022-29.
  7. Kostis JB, Wilson AC, Freudenberger RS, et al. Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol 2005;95:29-35.
  8. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium-channel blocker vs diuretic: The Antihypertensive an Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-97.
  9. Barzilay JI, Davis BR, Cutler JA, et al. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med 2006;166:2191-201.
  10. Zillich AJ, Garg J, Basu S, et al. Thiazide diuretics, potassium and the development of diabetes. A quantative review. Hypertension 2006;48:219-24.
  11. Чазова И.Е., Ратова Л.Г. Комбинированная терапия артериальной гипертонии // Сердце. 2005. Т. 4(3). С. 120-126.
  12. Sowers JR, Neuten JM, Saunders E, et al. Antihypertnensive efficacy of irbesartan/HCTZ in men and women with the metabolic syndrome and type 2 diabetes. J Clin Hypertens 2006;8:470-80.
  13. Derosa G, Ferrari I, Cicero AF. Irbesartan and hydrochlorothiazide association in the treatment of hypertension. Curr Vasc Pharmacol 2009;7(2):120-36.
  14. Patel A.; ADVANCE Collaborative Group, MacMahon S., Chalmers J. et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007;370(9590):829-40.
  15. Shah SU, Anhjum S, Littler WA. Use of diuretics in cardiovascular disease: (2) hypertension. Postgrad Med J 2004;80:271-76.
  16. Hypertension Detection and Follow-up Program Cooperative Group. Five-year findings of the hypertension detection and follow-up program. III. Reduction in stroke incidence among persons with high blood pressure. JAMA 1982;247(5):633-38.
  17. Kreeft JH, Langlois S, Ogilvie RI. Comparative trial of indapamide and hydrochlorothiazide in essential hypertension, with forearm plethysmography. J Cardiovasc Pharmacol 1984;6(4):622-26.
  18. Spence JD, Huff M, Barnett PA. Effects of indapamide versus hydrochlorothiazide on plasma lipids and lipoproteins in hypertensive patients: a direct comparison. Can J Clin Pharmacol 2000;7(1):32-37.
  19. Elliott WJ, Weber RR, Murphy MB. A double-blind, randomized, placebo-controlled comparison of the metabolic effects of low-dose hydrochlorothiazide and indapamide. J Clin Pharmacol 1991;31(8):751-57.
  20. Reyes AJ. Cardiovascular drugs and serum uric acid. Cardiovasc Drugs Ther 2003;17(5-6):397-414.
  21. Gurwitz JH, Kalish SC, Bohn RL, et al. Thiazide diuretics and the initiation of anti-gout therapy. J Clin Epidemiol 1997;50(8):953-59.
  22. Inaba M, Noguchi Y, Yamamoto T, et al. Effects of a low dose of indapamide, a diuretic, given daily or every-other-day on blood pressure and metabolic parameters. Hypertens Res.2004;27(3):141-45.
  23. Yamada H, Mishiro Y, Kusunose K, et al. Effects of additional administration of low-dose indapamide on patients with hypertension treated with angiotensin II receptor blocker. J Cardiovasc Pharmacol Ther 2010;15(2):145-50.
  24. Achimastos A, Liberopoulos E, Nikas S, et al. The effects of the addition of micronised fenofibrate on uric acid metabolism in patients receiving indapamide. Curr Med Res Opin 2002;18(2):59-63.
  25. Недогода С.В., Барыкина И.Н., Брель У.А. и др. Возможность коррекции Равелом СР факторов риска при артериальной гипертензии на фоне ожирения // Системные гипертензии. 2007. № 1. С. 14-18.
  26. Reisin E, Weir MR, Falkner B, et al. Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group. Hypertension 1997;30(1 Pt. 1):140-45.
  27. Emeriau JP, Knauf H, Pujadas JO, et al. A comparison of indapamide SR 1.5 mg with both amlodipine 5 mg and hydrochlorothiazide 25 mg in elderly hypertensive patients: a randomized double-blind controlled study. J Hypertens 2001;19(2):343-50.
  28. Luccioni R, Sever PS, Di Perri T, et al. An equivalence study of the safety and efficacy of a fixed-dose combination of perindopril with indapamide versus fixed-dose combinations of captopril with hydrochlorothiazide and enalapril with hydrochlorothiazide in the treatment of hypertension. J Hypertens 1995;13(12 Pt. 2):1847-51.
  29. Carter BL, Ernst ME, Cohen JD. hydrochlorothiazide versus chlorothalidone: evidence supporting their interchangeability. Hypertension 2004;43:4-9.
  30. Sumiye L, Vivian AS, Frisof KB, et al. Potassium loss associated with hydrochlorothiazide versus chlorthalidone. Clin Ther 1981;4(4):308-20.
  31. Izzo JL, Neutel JM, Silfani T, et al. Titration of HCTZ to 50 mg daily in individuals with stage 2 systolic hypertension pretreated with an angiotensin receptor blocker. J Clin Hypertens (Greenwich). 2007;9(1):45-48.
  32. Keyes JW, Breneman GM, Alvarez H. Chlorothiazide and hydrochlorothiazide in the treatment of congestive heart failure. Int Rec Med Gen Pract Clin 1959;172(8):454-60.
  33. Dormans TP, Gerlag PG. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure. Eur Heart J 1996;17(12):1867-74.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Bionika Media

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies